| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702377 | Surgical Oncology | 2017 | 8 Pages |
Abstract
Transarterial DEBIRI is safe and effective in the treatment of unresectable CRLM to the liver. Further studies are warranted to better define its role in the treatment algorithm of this patient subset.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Olaguoke MD, Meaghan Dendy, Johannes M. MD, Hyun S. MD,